Cart (0 Items)
Your cart is currently empty.
View Products
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Lumretuzumab Biosimilar - Anti-ERBB3 mAb - Research Grade |
|---|---|
| Source | CAS 1448327-63-6 |
| Species | Humanized |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery lead time in business days | 3-5 days if in stock; 3-5 weeks if production needed |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Lumretuzumab,RG-7116,RO5479599,ERBB3,anti-ERBB3 |
| Reference | PX-TA1357 |
| Note | For research use only. Not suitable for human use. |
| Isotype | IgG1-kappa |
Lumretuzumab has been investigated for the treatment of Neoplasms, Breast Cancer, Non-Small Cell Lung Cancer.
Immobilized Receptor tyrosine-protein kinase erbB-3(ERBB3)His Tag (cat. No.PX-P4724) at 0.5µg/mL (100µL/well) can bind to Lumretuzumab Biosimilar – Anti-ERBB3 mAb – Research Grade (cat. No. PX-TA1357) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450
Related products
Send us a message from the form below
Reviews
There are no reviews yet.